Aarkstore - Depression - Pipeline Review, H2 2014

1
Depression - Pipeline Review, H2 2014
Category Healthcare 

• Browse Complete Report -
• http//www.aarkstore.com/healthcare/63079/depressi
  on-pipeline-review

2
Depression - Pipeline Review, H2 2014
3
Summary

• Global Markets Directs, Depression - Pipeline
  Review, H2 2014, provides an overview of the
  Depressions therapeutic pipeline.This report
  provides comprehensive information on the
  therapeutic development for Depression, complete
  with comparative analysis at various stages,
  therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration (RoA)
  and molecule type, along with latest updates, and
  featured news and press releases. It also reviews
  key players involved in the therapeutic
  development for Depression and special features
  on late-stage and discontinued projects.
• Global Markets Directs report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications. The report is built using data and
  information sourced from Global Markets Directs
  proprietary databases, Company/University
  websites, SEC filings, investor presentations and
  featured press releases from company/university
  sites and industry-specific third party sources,
  put together by Global Markets Directs team.

4
Summary

• Drug profiles/records featured in the report
  undergoes periodic updation following a stringent
  set of processes that ensures that all the
  profiles are updated with the latest set of
  information. Additionally, processes including
  live news deals tracking, browser based
  alert-box and clinical trials registries tracking
  ensure that the most recent developments are
  captured on a real time basis.
• The report enhances decision making capabilities
  and help to create effective counter strategies
  to gain competitive advantage. It strengthens RD
  pipelines by identifying new targets and MOAs to
  produce first-in-class and best-in-class
  products.Note Certain sections in the report
  may be removed or altered based on the
  availability and relevance of data for the
  indicated disease.

5
Scope

• - The report provides a snapshot of the global
  therapeutic landscape of Depression- The report
  reviews key pipeline products under drug profile
  section which includes, product description, MoA
  and RD brief, licensing and collaboration
  details other developmental activities - The
  report reviews key players involved in the
  therapeutics development for Depression and
  enlists all their major and minor projects- The
  report summarizes all the dormant and
  discontinued pipeline projects - A review of the
  Depression products under development by
  companies and universities/research institutes
  based on information derived from company and
  industry-specific sources- Pipeline products
  coverage based on various stages of development
  ranging from pre-registration till discovery and
  undisclosed stages- A detailed assessment of
  monotherapy and combination therapy pipeline
  projects- Coverage of the Depression pipeline on
  the basis of target, MoA, route of administration
  and molecule type- Latest news and deals
  relating related to pipeline products

6
Reasons to buy

• Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies- Identify
  emerging players with potentially strong product
  portfolio and create effective counter-strategies
  to gain competitive advantage- Develop strategic
  initiatives by understanding the focus areas of
  leading companies- Identify and understand
  important and diverse types of therapeutics under
  development for Depression- Plan mergers and
  acquisitions effectively by identifying key
  players of the most promising pipeline- Devise
  corrective measures for pipeline projects by
  understanding Depression pipeline depth and focus
  of Indication therapeutics- Develop and design
  in-licensing and out-licensing strategies by
  identifying prospective partners with the most
  attractive projects to enhance and expand
  business potential and scope- Modify the
  therapeutic portfolio by identifying discontinued
  projects and understanding the factors that drove
  them from pipeline

7
Table of Content
List of Tables 7List of Figures 9Introduction
10Global Markets Direct Report Coverage
10Depression Overview 11Therapeutics
Development 12Pipeline Products for Depression -
Overview 12Pipeline Products for Depression -
Comparative Analysis 13Depression - Therapeutics
under Development by Companies 14Depression -
Therapeutics under Investigation by
Universities/Institutes 20Depression - Pipeline
Products Glance 22Late Stage Products
22Clinical Stage Products 23Early Stage
Products 24Unknown Stage Products 25Depression
- Products under Development by Companies 26
8
Table of Content
Depression - Products under Investigation by
Universities/Institutes 32Depression - Companies
Involved in Therapeutics Development 34AB
Science 34Acetylon Pharmaceuticals, Inc. 35Ache
Laboratorios Farmaceuticos S/A 36Adamas
Pharmaceuticals, Inc. 37Adamed Sp. z o.o.
38Addex Therapeutics Ltd 39Anavex Life Sciences
Corp. 40Angelini Group 41Angita B.V. 42ArisGen
SA 43Azevan Pharmaceuticals, Inc. 44
9
List Of Tables

• Number of Products under Development for
  Depression, H2 2014 19Number of Products under
  Development for Depression - Comparative
  Analysis, H2 2014 20Number of Products under
  Development by Companies, H2 2014 22Number of
  Products under Development by Companies, H2 2014
  (Contd..1) 23Number of Products under
  Development by Companies, H2 2014 (Contd..2)
  24Number of Products under Development by
  Companies, H2 2014 (Contd..3) 25Number of
  Products under Development by Companies, H2 2014
  (Contd..4) 26Number of Products under
  Investigation by Universities/Institutes, H2 2014
  28Comparative Analysis by Late Stage
  Development, H2 2014 29Comparative Analysis by
  Clinical Stage Development, H2 2014
  30Comparative Analysis by Early Stage
  Development, H2 2014 31

10
List Of Tables

• Comparative Analysis by Unknown Stage
  Development, H2 2014 32Products under
  Development by Companies, H2 2014 33Products
  under Development by Companies, H2 2014
  (Contd..1) 34Products under Development by
  Companies, H2 2014 (Contd..2) 35Products under
  Development by Companies, H2 2014 (Contd..3)
  36Products under Development by Companies, H2
  2014 (Contd..4) 37Products under Development by
  Companies, H2 2014 (Contd..5) 38Products under
  Investigation by Universities/Institutes, H2 2014
  39Products under Investigation by
  Universities/Institutes, H2 2014 (Contd..1)
  40Depression - Pipeline by AB Science, H2 2014
  41Depression - Pipeline by Acetylon
  Pharmaceuticals, Inc., H2 2014 42Depression -
  Pipeline by Ache Laboratorios Farmaceuticos S/A,
  H2 2014 43Depression - Pipeline by Adamas
  Pharmaceuticals, Inc., H2 2014 44Depression -
  Pipeline by Adamed Sp. z o.o., H2 2014 45

11
List of Figures

• Number of Products under Development for
  Depression, H2 2014 19 Number of Products under
  Development for Depression - Comparative
  Analysis, H2 2014 20 Number of Products under
  Development by Companies, H2 2014 21 Number of
  Products under Investigation by
  Universities/Institutes, H2 2014 27 Comparative
  Analysis by Clinical Stage Development, H2 2014
  30 Comparative Analysis by Early Stage Products,
  H2 2014 31 Assessment by Monotherapy Products,
  H2 2014 92 Number of Products by Top 10 Targets,
  H2 2014 93 Number of Products by Stage and Top
  10 Targets, H2 2014 93 Number of Products by Top
  10 Mechanism of Actions, H2 2014 97 Number of
  Products by Stage and Top 10 Mechanism of
  Actions, H2 2014 97 Number of Products by Top 10
  Routes of Administration, H2 2014 100

12
Related Reports

• Epilepsy Market in the US 2015-2019
• Global Ankylosing Spondylitis Market 2015-2019
• Sickle-cell Anemia Therapeutics Market in the US
  2015-2019
• Onchocerciasis (River Blindness) Global Clinical
  Trials Review, H2, 2014

13
Related Reports

• Mycoses Global Clinical Trials Review, H2, 2014
• Nosocomial Infections Global Clinical Trials
  Review, H2, 2014
• Orthomyxoviridae Infections Global Clinical
  Trials Review, H2, 2014
• Pediculosis (Head Lice Infestation) Global
  Clinical Trials Review, H2, 2014
• Healthcare Market Research Reports

14

• Depression - Pipeline Review, H2 2014
• Published Oct 2014 225 Pages
• Depression - Pipeline Review, H2 2014 report
  features investigational drugs from across globe
  covering over 20 therapy areas and nearly 3,000
  indications.
  Price

Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence 6000
15
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news